Amgen leukemia drug cures 39 percent of treated patients, study finds
![](https://dev.pacbiztimes.com/wp-content/uploads/2014/01/amgen-flagWEB-300x224.jpg)
Amgen’s new leukemia drug cured 39 percent of pediatric patients who received treatment, the Thousand Oaks company said Oct. 3 after publishing results of a new study in the Journal of Clinical Oncology. Blincyto, which treats a rare form of the disease known as precursor B-cell acute lymphoblastic leukemia, sent 27 patients out of 70 Read More →
Read More →NRG moves forward with Oxnard power plant site
![](https://dev.pacbiztimes.com/wp-content/uploads/2015/08/25-power-plant-color-web-300x224.jpg)
Despite a recent setback from the California Coastal Commission, Houston-based NRG Energy is pressing ahead with plans to build a new power plant along the Oxnard coast. If built, the company claims construction of the facility could have an economic impact of at least $93 million on the region. But the California Coastal Commission handed Read More →
Read More →![Premium Content](https://dev.pacbiztimes.com/wp-content/themes/e9bqxucyjgdpwjvsw8/images/premium.gif)
FDA gives big win to Amgen in biosimilars race
![](https://dev.pacbiztimes.com/wp-content/uploads/2015/07/20-amgen-300x224.jpg)
This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.
Read More →Fires delay satellite launch at Vandenberg Air Force Base
![](https://dev.pacbiztimes.com/wp-content/uploads/2016/09/28-rocket-300x224.jpg)
Liftoff of a long delayed earth imaging satellite has been pushed back further by two wildfires burning on Vandenberg Air Force Base. Originally scheduled for Sept. 16, the launch of the WorldView4 earth imaging satellite was first pushed back at the last minute until Sept. 18 because of a minor leak in one of the Read More →
Read More →